With growing recognition of the prevalence of mental health issues in the US population, now is the time to better understand and meaningfully address the behavioral health needs of lower-income earners. According to the National Institute of Mental Health, low-income individuals are 2 to 5 times more likely to experience a diagnosable mental disorder than individuals in the highest socioeconomic group. Perhaps more concerning is the fact that little is known about how low-wage earners use and adhere to evidence-based behavioral health services.
Complicating the issue is that low-wage earners face an array of barriers to mental health services. The movement of behavioral health clinicians out of health plan networks has reduced in-network provider access. Hourly employees may also have to choose between earning wages or sacrificing pay to seek care during the workday. Growing employer adoption of high-deductible health plans, stifled wage growth, limited in-network access, and increasing deductibles compound healthcare affordability issues and may well contribute to increased stress and exacerbation of pre-existing mental health issues.
Our recent research has characterized high-level health benefits utilization patterns among workers by wage level, but it did not specifically address behavioral health services use. We are unaware of any published analyses assessing behavioral healthcare use among low-income earners. However, on the basis of preliminary data, we hypothesize that low-wage workers are less likely to access ambulatory behavioral health services or be taking psychoactive medications and are more likely to have behavioral health—related emergency department visits and hospitalizations. Those with both behavioral health issues and chronic conditions such as diabetes or heart disease (also more prevalent in lower-income populations) are perhaps at the greatest risk for suboptimal condition management.
Ongoing research will be helpful in assessing new models of behavioral health service delivery and, importantly, the efficacy of integrated primary care and behavioral healthcare, particularly for low-income workers. There is also an urgent need to better understand the potential efficacy and outcomes of less costly behavioral health services for low-income workers, including employee assistance programs and telebehavioral health. To our knowledge, this is yet another area with a limited research base that warrants further exploration. Findings may well yield new insights, prompting changes in benefit design and communications to encourage greater patient awareness, acceptance, and use.
From a broader perspective, social determinants of health (SDoH), including wage, have particular significance for low-income populations; their relation to the prevalence and severity of mental health disorders also merits more in-depth analysis. If strong associations are identified, a case can be made to direct additional resources toward social supports. For employers, and especially those in the business of healthcare, recognition of the impact of SDoH on employee well-being, engagement, and business performance can likely further justify additional resource support, including critical review of mental health benefits offerings.
These considerations assume particular significance for healthcare organizations considering risk-based contracting. An understanding of the interrelationship among behavioral health conditions, patient SDoH concerns, and chronic illness can help to better target service delivery priorities and thereby improve treatment effectiveness and outcomes.
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
February 20th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes reflections from a thought leader on what has changed over the past 3 decades and what’s next for managed care. The February issue features a retrospective by Richard J. Gilfillan, MD, former director of the Center for Medicare and Medicaid Innovation; and Donald M. Berwick, MD, MPP, former administrator of CMS.
Read More
Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans
February 10th 2025This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.
Read More